We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 1,724 results
  1. Impacts of ABCG2 loss of function variant (p. Gln141Lys, c.421 C > A, rs2231142) on lipid levels and statin efficiency: a systematic review and meta-analysis

    Background

    The latest evidence indicates that ATP-binding cassette superfamily G member 2 (ABCG2) is critical in regulating lipid metabolism and...

    Yang Liu, Yuan Chen, ... Zhi Luo in BMC Cardiovascular Disorders
    Article Open access 08 April 2024
  2. A naturally occurring variant of SHLP2 is a protective factor in Parkinson’s disease

    Mitochondrial DNA single nucleotide polymorphisms (mtSNPs) have been associated with a reduced risk of develo** Parkinson’s disease (PD), yet the...

    Su-Jeong Kim, Brendan Miller, ... Pinchas Cohen in Molecular Psychiatry
    Article Open access 03 January 2024
  3. Fast, accurate, and racially unbiased pan-cancer tumor-only variant calling with tabular machine learning

    Accurately identifying somatic mutations is essential for precision oncology and crucial for calculating tumor-mutational burden (TMB), an important...

    R. Tyler McLaughlin, Maansi Asthana, ... David L. Masica in npj Precision Oncology
    Article Open access 07 January 2023
  4. Germline rare deleterious variant load alters cancer risk, age of onset and tumor characteristics

    Recent studies show that rare, deleterious variants (RDVs) in certain genes are critical determinants of heritable cancer risk. To more...

    Myvizhi Esai Selvan, Kenan Onel, ... Zeynep H. Gümüş in npj Precision Oncology
    Article Open access 27 January 2023
  5. High-resolution structural variant profiling of myelodysplastic syndromes by optical genome map** uncovers cryptic aberrations of prognostic and therapeutic significance

    Chromosome banding analysis (CBA) remains the standard-of-care for structural variant (SV) assessment in MDS. Optical genome map** (OGM) is a...

    Hui Yang, Guillermo Garcia-Manero, ... Rashmi Kanagal-Shamanna in Leukemia
    Article Open access 01 August 2022
  6. A HUWE1 defect causes PARP inhibitor resistance by modulating the BRCA1-∆11q splice variant

    Although PARP inhibitors (PARPi) now form part of the standard-of-care for the treatment of homologous recombination defective cancers, de novo and...

    Stephen J. Pettitt, Nan Shao, ... Christopher J. Lord in Oncogene
    Article Open access 25 July 2023
  7. Detection of enterovirus RNA in peripheral blood mononuclear cells correlates with the presence of the predisposing allele of the type 1 diabetes risk gene IFIH1 and with disease stage

    Aims/hypothesis

    Enteroviral infection has been implicated consistently as a key environmental factor correlating with the appearance of autoimmunity...

    Amir-Babak Sioofy-Kho**e, Sarah J. Richardson, ... Martin Eichmann in Diabetologia
    Article Open access 22 July 2022
  8. A complex pheotype in a girl with a novel heterozygous missense variant (p.Ile56Phe) of the GNAS gene

    Background

    GNAS is a complex gene that encodes Gsα, a signaling protein that triggers a complex network of pathways. Heterozygous inactivating...

    Paolo Cavarzere, Andrea Gastaldi, ... Franco Antoniazzi in Orphanet Journal of Rare Diseases
    Article Open access 23 February 2022
  9. The schizophrenia-associated variant in SLC39A8 alters protein glycosylation in the mouse brain

    A missense mutation (A391T) in SLC39A8 is strongly associated with schizophrenia in genomic studies, though the molecular connection to the brain is...

    Robert G. Mealer, Sarah E. Williams, ... Richard D. Cummings in Molecular Psychiatry
    Article 08 March 2022
  10. RANKL inhibition reduces lesional cellularity and Gαs variant expression and enables osteogenic maturation in fibrous dysplasia

    Fibrous dysplasia (FD) is a rare, disabling skeletal disease for which there are no established treatments. Growing evidence supports inhibiting the...

    Luis F. de Castro, Jarred M. Whitlock, ... Alison M. Boyce in Bone Research
    Article Open access 20 February 2024
  11. Dynamic monitoring of UBA1 somatic mutations in patients with relapsing polychondritis

    Background

    Commonly clinically diagnosed with relapsing polychondritis (RP), vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic syndrome (VEXAS)...

    Suying Duan, Haiyang Luo, ... Yuming Xu in Orphanet Journal of Rare Diseases
    Article Open access 02 January 2024
  12. Prevalence of pathogenic germline variants in the circulating tumor DNA testing

    Background

    Somatic and germline variants are not distinguishable by circulating tumor DNA (ctDNA) testing without analyzing non-tumor samples....

    Yoshihiro Yamamoto, Keita Fukuyama, ... Manabu Muto in International Journal of Clinical Oncology
    Article Open access 23 July 2022
  13. A Conformational Variant of p53 (U-p53AZ) as Blood-Based Biomarker for the Prediction of the Onset of Symptomatic Alzheimer’s Disease

    Background

    Ongoing research seeks to identify blood-based biomarkers able to predict onset and progression of Alzheimer’s disease (AD).

    ...
    Simona Piccirella, L. Van Neste, ... P. Kinnon in The Journal of Prevention of Alzheimer's Disease
    Article Open access 17 May 2022
  14. Identification and characterization of the long non-coding RNA NFIA-AS2 as a novel locus for body mass index in American Indians

    Background

    Genome-wide association studies have shown that body mass index (BMI), an estimate of obesity, is highly polygenic. Individual variants...

    Khushdeep Bandesh, Michael Traurig, ... Leslie J. Baier in International Journal of Obesity
    Article Open access 17 February 2023
  15. Deriving tumor purity from cancer next generation sequencing data: applications for quantitative ERBB2 (HER2) copy number analysis and germline inference of BRCA1 and BRCA2 mutations

    Tumor purity, or the relative contribution of tumor cells out of all cells in a pathological specimen, influences mutation identification and...

    Stephanie E. Siegmund, Danielle K. Manning, ... Fei Dong in Modern Pathology
    Article 28 July 2022
  16. Maternal mosaicism in SSBP1 causing optic atrophy with retinal degeneration: implications for genetic counseling

    Background

    Optic atrophy-13 with retinal and foveal abnormalities (OPA13) (MIM #165510) is a mitochondrial disease in which apparent bilateral optic...

    Yin-Hsi Chang, Eugene Yu-Chuan Kang, ... Nan-Kai Wang in Orphanet Journal of Rare Diseases
    Article Open access 31 May 2023
  17. Compartment-specific mutational landscape of clonal hematopoiesis

    Clonal hematopoiesis (CH) is characterized by somatic mutations in blood cells of individuals without hematologic disease. While the mutational...

    Luise Hartmann, Judith S. Hecker, ... Klaus H. Metzeler in Leukemia
    Article Open access 21 September 2022
  18. Clonal evolution in liver cancer at single-cell and single-variant resolution

    Genetic heterogeneity of tumor is closely related to its clonal evolution, phenotypic diversity and treatment resistance, and such heterogeneity has...

    **anbin Su, Linan Zhao, ... Ze-Guang Han in Journal of Hematology & Oncology
    Article Open access 02 February 2021
  19. Deep exome sequencing identifies enrichment of deleterious mosaic variants in neurodevelopmental disorder genes and mitochondrial tRNA regions in bipolar disorder

    Bipolar disorder (BD) is a global medical issue, afflicting around 1% of the population with manic and depressive episodes. Despite various genetic...

    Masaki Nishioka, Jun Takayama, ... Tadafumi Kato in Molecular Psychiatry
    Article Open access 30 May 2023
  20. Quantification of cerebrospinal fluid tumor DNA in lung cancer patients with suspected leptomeningeal carcinomatosis

    Cerebrospinal fluid tumor-derived DNA (CSF-tDNA) analysis is a promising approach for monitoring the neoplastic processes of the central nervous...

    Tej D. Azad, Shigeki Nanjo, ... Maximilian Diehn in npj Precision Oncology
    Article Open access 28 May 2024
Did you find what you were looking for? Share feedback.